RECURRENT TUMOR
Clinical trials for RECURRENT TUMOR explained in plain language.
Never miss a new study
Get alerted when new RECURRENT TUMOR trials appear
Sign up with your email to follow new studies for RECURRENT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets deadly brain cancer in early trial
Disease control Recruiting nowThis study tests a new drug called LMP744 in 40 adults whose glioblastoma (a type of brain cancer) has come back after standard treatment. The drug is given through a vein for 5 days each month for up to a year. The goal is to see if it can shrink tumors or slow their growth.
Matched conditions: RECURRENT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated May 26, 2026 09:40 UTC
-
Laser zaps recurring brain tumors in new trial
Disease control Recruiting nowThis study is for people whose brain tumors have returned after radiation therapy. It compares a laser-based treatment (LITT) with standard care to see which better controls tumor growth and reduces the need for steroids. About 261 adults with brain metastases will take part.
Matched conditions: RECURRENT TUMOR
Phase: NA • Sponsor: Monteris Medical • Aim: Disease control
Last updated May 26, 2026 09:29 UTC